The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- ITeos Therapeutics ITOS - P/E: 2.41
- Organogenesis Hldgs ORGO - P/E: 8.68
- Ikena Oncology IKNA - P/E: 4.65
- LAVA Therapeutics LVTX - P/E: 0.33
- Co-Diagnostics CODX - P/E: 4.02
ITeos Therapeutics's earnings per share for Q1 sits at $1.82, whereas in Q4, they were at 4.88. Organogenesis Hldgs has reported Q1 earnings per share at $0.01, which has decreased by 97.5% compared to Q4, which was 0.4. Ikena Oncology has reported Q1 earnings per share at $-0.47, which has decreased by 771.43% compared to Q4, which was 0.07. Most recently, LAVA Therapeutics reported earnings per share at $-0.41, whereas in Q4 earnings per share sat at $-0.38. This quarter, Co-Diagnostics experienced an increase in earnings per share, which was $0.25 in Q4 and is now $0.34.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.